PUMA BIOTECHNOLOGY, INC. (PBYI) Return on equity 2017–2025
PUMA BIOTECHNOLOGY, INC. (PBYI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
23.9%FY2025 · since FY2017: -547.7% → 23.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 23.9% | -9.0 pp |
| FY2024 | 32.9% | -7.5 pp |
| FY2023 | 40.4% | +40.4 pp |
| FY2022 | 0.0% | — |
| FY2019 | -432.9% | -101.8 pp |
| FY2018 | -331.1% | +216.7 pp |
| FY2017 | -547.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice